Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-05-16 Purchase |
2023-05-18 4:44 pm |
Taysha Gene Therapies Inc. | TSHA | Nagendran Sukumar President and Head of R&D |
5,000 | $0.68 | $3,400 | 34,226 (Direct) |
View |
| 2022-02-02 Purchase |
2022-02-03 09:21 am |
Taysha Gene Therapies Inc. | TSHA | Nagendran Sukumar Director |
10,000 | $8.01 | $80,100 | 29,226 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-02 Option Award |
2025-01-03 5:36 pm |
N/A 2035-01-02 |
Taysha Gene Therapies Inc. | TSHA | Nagendran Sukumar President and Head of R&D |
324,500 | $0 | 1,546,843 (Direct) |
View |
| 2024-06-11 Option Award |
2024-06-13 4:08 pm |
N/A 2034-06-11 |
Solid Biosciences Inc. | SLDB | Nagendran Sukumar Director |
34,400 | $0 | 34,400 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:42 pm |
N/A 2034-01-02 |
Taysha Gene Therapies Inc. | TSHA | Nagendran Sukumar President and Head of R&D |
863,617 | $0 | 1,761,460 (Direct) |
View |
| 2023-12-14 Option Award |
2023-12-18 4:47 pm |
N/A 2033-12-14 |
Taysha Gene Therapies Inc. | TSHA | Nagendran Sukumar President and Head of R&D |
334,005 | $0 | 334,005 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 9:19 pm |
N/A 2033-06-06 |
Solid Biosciences Inc. | SLDB | Nagendran Sukumar Director |
9,650 | $0 | 9,650 (Direct) |
View |
| 2022-12-30 Option Award |
2023-01-04 4:51 pm |
N/A 2032-12-30 |
Taysha Gene Therapies Inc. | TSHA | Nagendran Sukumar President and Head of R&D |
790,093 | $0 | 790,093 (Direct) |
View |
| 2022-12-13 Option Award |
2022-12-15 6:07 pm |
N/A 2032-12-13 |
Solid Biosciences Inc. | SLDB | Nagendran Sukumar Director |
9,650 | $0 | 9,650 (Direct) |
View |
| 2022-06-17 Option Award |
2022-06-22 4:39 pm |
N/A 2032-06-17 |
Taysha Gene Therapies Inc. | TSHA | Nagendran Sukumar Director |
15,500 | $0 | 15,500 (Direct) |
View |
| 2022-06-07 Option Award |
2022-06-09 5:11 pm |
N/A 2032-06-07 |
Solid Biosciences Inc. | SLDB | Nagendran Sukumar Director |
51,000 | $0 | 51,000 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-21 5:04 pm |
N/A 2031-06-17 |
Taysha Gene Therapies Inc. | TSHA | Nagendran Sukumar Director |
15,500 | $0 | 15,500 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-21 4:00 pm |
N/A 2031-06-16 |
Solid Biosciences Inc. | SLDB | Nagendran Sukumar Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2020-09-28 Conversion |
2020-09-30 4:37 pm |
N/A N/A |
Taysha Gene Therapies Inc. | TSHA | Nagendran Sukumar Director |
36,873 | $0 | 19,226 (Direct) |
View |
| 2020-09-23 Option Award |
2020-09-25 5:12 pm |
N/A 2030-09-23 |
Taysha Gene Therapies Inc. | TSHA | Nagendran Sukumar Director |
31,000 | $0 | 31,000 (Direct) |
View |
Ownership |
2020-09-23 8:28 pm |
N/A N/A |
Taysha Gene Therapies Inc. | TSHA | Nagendran Sukumar Director |
0 | $0 | 27,397 (Direct) |
View |
| 2020-06-16 Option Award |
2020-06-18 4:18 pm |
N/A 2030-06-16 |
Solid Biosciences Inc. | SLDB | Nagendran Sukumar Director |
40,000 | $0 | 40,000 (Direct) |
View |